Anti-Mouse IL13 mIgG2a Antibody (BAK209B11)
货号
GM-88168MAB
规格
1 mg
5 mg
5 mg*5 vials
50 mg
50 mg*2 vials
立即询价
数据展示
产品简介
相关产品
数据展示
On SDS-PAGE under reducing (R)/non-reducing(N-R) condition. The purity of the protein is greater than 95%.
The purity of this product is more than 95% verified by SEC-HPLC.
Mouse IL-13 Protein; His Tag (Catalog # GM-88166RP) was immobilized at 2 μg/ml (100 μL/well). Increasing concentrations of Anti-Mouse IL13 mIgG2a Antibody (BAK209B11) (Catalog # GM-88168MAB) were added.
产品简介

Expression System     CHO

Aggregation               < 5% as determined by SEC-HPLC

Purity                          > 95% as determined by SDS-PAGE

Specificity                   Detects IL13

Target                          IL13

Clone                           BAK209B11

Other Names              IL-13, P600

Source/Isotype           Monoclonal Mouse IgG2a kappa

Application                 Bioactivity-ELISA

Gene ID                       10090 (mouse)

Description                 IL-13 is a cytokine produced by Th2 cells, mast cells, eosinophil granulocyte, ilc2s, etc. . It mainly acts on epithelial tissues such as the airway, skin and intestine, and participates in the regulation of mucosal barrier, mucus secretion, inflammatory cell recruitment and excessive airway remodeling. Sharing a signaling pathway with IL-4(via the IL-4R α/IL-13R α1 complex) , plays a critical role in scenarios such as immune responses, allergies, and parasitic infections. The IL-13 gene is located in a region of a Upstream and downstream shared element, and its expression is regulated by transcription factors such as GATA3 and STAT6 in response to Th2 deflection signals. IL-13 signaling can be modulated by receptor availability, soluble baits, and genetic variants that affect receptor binding or expression. IL-13 activates signaling pathways such as JAK-STAT (especially Stat6) by binding to the complex of receptor IL-4R α with IL-13R α1/2, resulting in altered gene expression and amplification of inflammatory responses.

Formulation                Phosphate-buffered solution, pH 7.2-7.4

Formulation                < 1 EU/mg, determined by LAL gel clotting assay

相关产品
Anti-Mouse IL13 mIgG2a Antibody (BAK209B11)
货号
GM-88168MAB
规格
1 mg
5 mg
5 mg*5 vials
50 mg
50 mg*2 vials
立即询价
数据展示
产品简介
相关产品
数据展示
On SDS-PAGE under reducing (R)/non-reducing(N-R) condition. The purity of the protein is greater than 95%.
The purity of this product is more than 95% verified by SEC-HPLC.
Mouse IL-13 Protein; His Tag (Catalog # GM-88166RP) was immobilized at 2 μg/ml (100 μL/well). Increasing concentrations of Anti-Mouse IL13 mIgG2a Antibody (BAK209B11) (Catalog # GM-88168MAB) were added.
产品简介

Expression System     CHO

Aggregation               < 5% as determined by SEC-HPLC

Purity                          > 95% as determined by SDS-PAGE

Specificity                   Detects IL13

Target                          IL13

Clone                           BAK209B11

Other Names              IL-13, P600

Source/Isotype           Monoclonal Mouse IgG2a kappa

Application                 Bioactivity-ELISA

Gene ID                       10090 (mouse)

Description                 IL-13 is a cytokine produced by Th2 cells, mast cells, eosinophil granulocyte, ilc2s, etc. . It mainly acts on epithelial tissues such as the airway, skin and intestine, and participates in the regulation of mucosal barrier, mucus secretion, inflammatory cell recruitment and excessive airway remodeling. Sharing a signaling pathway with IL-4(via the IL-4R α/IL-13R α1 complex) , plays a critical role in scenarios such as immune responses, allergies, and parasitic infections. The IL-13 gene is located in a region of a Upstream and downstream shared element, and its expression is regulated by transcription factors such as GATA3 and STAT6 in response to Th2 deflection signals. IL-13 signaling can be modulated by receptor availability, soluble baits, and genetic variants that affect receptor binding or expression. IL-13 activates signaling pathways such as JAK-STAT (especially Stat6) by binding to the complex of receptor IL-4R α with IL-13R α1/2, resulting in altered gene expression and amplification of inflammatory responses.

Formulation                Phosphate-buffered solution, pH 7.2-7.4

Formulation                < 1 EU/mg, determined by LAL gel clotting assay

Expression System     CHO

Aggregation               < 5% as determined by SEC-HPLC

Purity                          > 95% as determined by SDS-PAGE

Specificity                   Detects IL13

Target                          IL13

Clone                           BAK209B11

Other Names              IL-13, P600

Source/Isotype           Monoclonal Mouse IgG2a kappa

Application                 Bioactivity-ELISA

Gene ID                       10090 (mouse)

Description                 IL-13 is a cytokine produced by Th2 cells, mast cells, eosinophil granulocyte, ilc2s, etc. . It mainly acts on epithelial tissues such as the airway, skin and intestine, and participates in the regulation of mucosal barrier, mucus secretion, inflammatory cell recruitment and excessive airway remodeling. Sharing a signaling pathway with IL-4(via the IL-4R α/IL-13R α1 complex) , plays a critical role in scenarios such as immune responses, allergies, and parasitic infections. The IL-13 gene is located in a region of a Upstream and downstream shared element, and its expression is regulated by transcription factors such as GATA3 and STAT6 in response to Th2 deflection signals. IL-13 signaling can be modulated by receptor availability, soluble baits, and genetic variants that affect receptor binding or expression. IL-13 activates signaling pathways such as JAK-STAT (especially Stat6) by binding to the complex of receptor IL-4R α with IL-13R α1/2, resulting in altered gene expression and amplification of inflammatory responses.

Formulation                Phosphate-buffered solution, pH 7.2-7.4

Formulation                < 1 EU/mg, determined by LAL gel clotting assay

相关产品
Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交